Potential indications for octreotide in endocrinology-Reference-Cited by-同舟云学术

Potential indications for octreotide in endocrinology

Published:1992-09 Issue:9 Volume:41 Page:91-98
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

von Werder Klaus,Faglia Giovanni

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. Is there a real medical treatment for the “non-secreting” pituitary adenomas?;Liuzzi,1991

2. Positron emission tomography for the in vivo characterization and follow-up of treatment in pituitary adenomas;Muhr;Adv Biosci,1988

3. Response of luteinizing hormone-secreting pituitary adenomas to a long-acting somatostatin analogue;Vos;Acta Endocrinol,1988

4. Plasma alpha-subunit levels during the treatment of pituitary adenomas with the somatostatin analog SMS 201-995;Sassolas;Horm Res,1988

5. Quick improvement of visual field complications due to extensive nonfunctioning hypothalamic or pituitary tumors with a somatostatin analog (SMS 201-995);Renard;J Endocrinol Invest,1990

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endokrine Tumoren des gastroenteropankreatischen Systems;Praxis der Viszeralchirurgie;2012-11-09

2. Effects of long-acting somatostatin analogues on adrenal growth and phosphoribosyl pyrophosphate formation in experimental diabetes;International Journal of Experimental Pathology;2012-01-20

3. Review article: anti-diarrhoeal pharmacology and therapeutics;Alimentary Pharmacology & Therapeutics;2007-03-31

4. Komplexe Hypophysenerkrankungen;Klinische Endokrinologie und Stoffwechsel;2001

5. Endokrine Tumoren des gastroenteropankreatischen Systems;Praxis der Viszeralchirurgie;2000